版本:
中国

BRIEF-Kite Pharma reports Q1 non-GAAP loss per share of $1.28

May 8 Kite Pharma Inc

* Kite reports first quarter financial results

* Q1 non-GAAP loss per share $1.28 excluding items

* Q1 loss per share $1.74

* Q1 revenue $9.8 million

* Q1 revenue view $12.3 million -- Thomson Reuters I/B/E/S

* Q1 earnings per share view $-1.71 -- Thomson Reuters I/B/E/S

* Continues to expect full year 2017 net cash burn to be between $325 million and $340 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐